chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore throat, headache, cough, neck pain times 2 days. Stated she was fine the first day, second and third day she developed flu like symptoms. On day five, she developed lymph node swelling, severe headache rated 10/10, stated pain is radiating up from ther neck causing her not to be able to turn neck. Temperature 102.3, BP 151/103
He was normal. He went to sleep and never woke up. 11 days after his vaccines.
ITCHING EARS; ITCHING THROAT; PELVIC CRAMP; CHILLS; POUNDING HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 04-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced itching ears. On APR-2021, the subject experienced itching throat. On APR-2021, the subject experienced pelvic cramp. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced pounding headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the itching ears, itching throat, pelvic cramp, pounding headache and chills was not reported. This report was non-serious.
severely eyes burning; eyes were very dry; has headache; nasal cavity dry- felt very dry inside; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (severely eyes burning), DRY EYE (eyes were very dry), HEADACHE (has headache) and NASAL DRYNESS (nasal cavity dry- felt very dry inside) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced EYE IRRITATION (severely eyes burning), DRY EYE (eyes were very dry), HEADACHE (has headache) and NASAL DRYNESS (nasal cavity dry- felt very dry inside). At the time of the report, EYE IRRITATION (severely eyes burning), DRY EYE (eyes were very dry), HEADACHE (has headache) and NASAL DRYNESS (nasal cavity dry- felt very dry inside) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
10 minutes post 2nd vaccination patient passed out and had shortness of breath.  Patient was administered Epi via Epipen and transported to the hospital.
Post vax, the pt had slight redness at injection site. Treated with cold and warm compresses.
Information has been received from a physician concerning a 12 year old female who on an unspecified date was vaccinated with the first dose of Gardasil, IM. Concomitant medication was not reported. On 23-MAR-2007, the patient got her period, it has not ended and it has been  14 days as of today. The patient sought unspecified medical attention. The outcome and action taken were not reported. Additional information has been requested.
Tired; Entire arm sore after; Body aches; Headache; Fatigue; Intense dizzy spells; Developed a bad rash spreading from both triceps down both lats; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 11Apr2021 at 16:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure , asthma, sjogren's syndrome, fibromyalgia, known allergies  to tea tree, turkey and gold. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), chlortalidone (CHLORTHALIDONE) and omeprazole (MANUFACTURER UNKNOWN); all taken for an unknown indication on an unknown date and unknown if ongoing. The patient previously took propylene glycol (MANUFACTURER UNKNOWN), formaldehyde solution (FORMALDEHYDE), glutaral (MANUFACTURER UNKNOWN), propolis (MANUFACTURER UNKNOWN), carbamazepine(CARMINE), 2-hydroxyethyl methacrylate (MANUFACTURER UNKNOWN), p-phenylenediamine(MANUFACTURER UNKNOWN), aminopropylon (MANUFACTURER UNKNOWN), dimethylaminopropylamine and ethyl 2-cyanoacrylate (MANUFACTURER UNKNOWN) and experienced drug allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, at 17:00, the patient was tired and entire arm sore after. She had body aches, headache, and fatigue and intense dizzy spells for the next week. She developed a bad rash spreading from both triceps down both lats, which progressively got worse over the next week and a half until prescribed prednisone. The event rash started to calm down after second dose of prednisone, but not gone. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with protopic, antihistamine, antibiotic and prednisone. Since the vaccination, the patient had been tested for COVID_19. On 22Apr2021, the patient underwent lab test and procedures which included SARS CoV-2 Antigen carestart 87811 (Nasal Swab) and the result was negative. The clinical outcome of the events tired, entire arm sore after, body aches, headache, fatigue and intense dizzy spells for the next week was not resolved. The clinical outcome of the event developed a bad rash spreading from both triceps down both lats was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
he had Covid19 a week after the 1st dose; he had Covid19 a week after the 1st dose; he was still experiencing arm pain on his injection site (right arm) until now/pain was pretty bad sometimes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 05Nov2021 18:00 (Batch/Lot number: unknown) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: Patient History: No. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2021, outcome "unknown" and all described as "he had Covid19 a week after the 1st dose"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "not recovered", described as "he was still experiencing arm pain on his injection site (right arm) until now/pain was pretty bad sometimes". Therapeutic measures were not taken as a result of covid-19, vaccination site pain.  The lot number for bnt162b2 was not provided and will be requested during follow up.
sore and tenderness on left arm; soreness on left arm; slight HA (headache) in the morning; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number: EH9899), via an unspecified route of administration on the left arm on 15Dec2020 09:45 at a single dose for immunization. Medical history included iron deficiency and was diagnosed with COVID-19 on an unspecified date; no known allergies. Concomitant medications included ascorbic acid (VIT C), tocopherol (VIT. E), cetirizine hydrochloride (ALERCET). The patient did not have other vaccinations within four weeks prior to the COVID vaccine. The patient experienced slight HA (headache) in the morning of day 0 (15Dec2020), occasional HA and increased soreness on left arm on day 1 (16Dec2020), still sore and experienced tenderness on left arm on days 2 to 4 but was mild at the time of report. The events were reported as non-serious. The patient took Tylenol and applied heating pad on her left arm. She was diagnosed with COVID prior to the vaccination and has not been tested for COVID post-vaccination. Outcome of the events was recovering.
Paitient had fever for 5 days and broke out in skin rash on body from neck to ankles
No adverse events reported, was instructed to complete VAERS form due to age 16 at time of vaccination.
pt devel tightness in chest about 2 days post vax which is cont over 2month;very anxious since vax given;still w/sx had near syncopal episode also during first month post vax;saw MD 3mo post vax BP 160/100, R16, chol inc, LDL inc;
This spontaneous report was received from a nurse via a company representative regarding at least 10 unspecified patients. The patients' medical history, allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported. On an unspecified date, the patients were vaccinated with M-M-R II (dose, frequency, strength, anatomical location, route of administration, lot number and expiration date were not reported) for prophylaxis. On an unknown date, the patients produced negative titers (antibody test negative). It was unknown if a treatment was given for the adverse event. The outcome regarding the antibody test negative was unknown. The relatedness between the event and M-M-R II was not provided. Furthermore, no product quality complaint (PQC) was involved.
This spontaneous report was received from a registered nurse and refers to a 5-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with a dose of PROQUAD subcutaneously in the abdomen (dose, frequency, lot# and expiration date were not reported). No adverse effects were reported. No causality assessment was reported.
March 4, 2021 new onset nasal congestion, loss of taste & smell. COVID-19 PCR positive.
pt recv 2 doses of vax MARCH & MAY96 & pt exp negative titer;
at around noon the day following my shot, I started feeling soreness all over my body. I took aleve. I felt some chills and a slight headache. These lasted until Sunday. Monday I started feeling very tired, very week, and still sore in my arms and a little in my legs. I took aleeve. Tuesday I still felt lingering soreness but no headache. I started feeling anxiety towards the end of my workday. At around 4pm I started to feel my legs quivering as if I had just run several miles and my muscles were week. This gave me anxiety as I was still working and assisting clients. at around 4:15 I started feeling like I was going to break out in hives around my neck area, which does sometimes happen to me. I got home and around 7pm I took a Zyrtec, but by that point hives started forming on my neck and head. I felt my lip start to swell. I woke up at about 3am on Wednesday to find both of my lips swollen and I took a Benadryl and went back to bed. I woke up at about 7am and my eyes were both swollen almost completely shut and my lips were swollen. I could feel itchiness from incoming hives around my neck and shoulders. I took two Benadryl and rested all day. The swelling mostly went down by the end of the day and I continued to nurse the Benadryl. I saw my doctor on the 15th. He advised how to proceed and prepare  with the second dose and referred me to an allergist.
pt exp encephalitic response p/vax, w/choreoathetoid movements exquisite irritability, abn eye movements, disconjugate gaze; neuro/cardiology/ophthalmic metabolic work up done, extensive diagnostic studies done
Around 5pm on 5/1 started with overall fatigue and muscle aches and weakness. Within 30 minutes had chills and uncontrollable shaking and fever shot to 102.2 and lasted throughout the night. Also, had a horrible headache in which pain relievers did not help. The next day I felt better, but was still exhausted and weak. Fever has disappeared.  By 5/3 I felt more like my normal self.
Burning in the arm around the injection site. Light-head, fatigue. Heart palpitations that lasted 3 days. Chest pressure, shortness of breath.
Initial and follow-up Information has been received from a nurse practitioner, concerning a 15-month-old male infant with eczema, who on 20-OCT-2008 received the first dose of 0.5 ml VARIVAX (Merck) (lot # 661661/0995X) via subcutaneous route on his right leg. Concomitant vaccinations included the fourth dose of PREVNAR (lot # C68312) IM in the left leg, the first dose of HAVRIX (lot # B257AA) IM in the right leg, and the first dose of FLUZONE (lot # UT2787AA) IM in the left leg. On 30-OCT-2008 (previously reported as 29-OCT-2008), 10 days post vaccination, the patient presented at office with 3 "reddish yellow" vesicles on his leg around the injection site. His mother was advised to give him BENADRYL PRN. At the time of reporting, the patient's outcome was unknown. Additional information is not expected.
ADMINISTRATION OF AN EXPIRED VACCINE; This spontaneous report received from a pharmacist concerned an over 18 years old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1, unspecified manufacturer) (suspension for injection, route of admin not reported, batch number and expiry not reported) dose was not reported, 1 total, administered on an unspecified date for prophylactic vaccination. No adverse events reported post primary vaccination (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 212A21A, and expiry: 21-DEC-2021) dose was not reported, 1 total, administered on 22-DEC-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 22-DEC-2021, the pharmacist administered an expired Janssen covid-19 vaccine (booster dose) to the patient (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of an expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211250793.
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a elderly female patient who received SHINGRIX for prophylaxis. Concomitant products included SHINGRIX. In March 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site erythema, injection site pain and injection site warmth. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema, injection site pain and injection site warmth were recovered/resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema, injection site pain and injection site warmth to be related to SHINGRIX. Additional information was reported as follows: The patient received the 2nd dose of SHINGRIX, 2 months after receiving the 1st dose. After vaccination, later within 12 hours, the patient experienced similar symptoms as experienced with the 1st dose but were less severe. The events lasted for a period of approximately 1 week. The patient was vaccinated with the 2nd dose under normal circumstances the same way as the pharmacy always administered. This case was linked with case US2018120276 (1st dose), reported by the same reporter for the same patient.
Nausea; Headache; No appetite; Dizziness; Does not feel well; Sick to her stomach; Swollen Arm /knot on arm; Itchy Arm; Sore Arm; Spent 2 days in bed; This non-serious case was reported by a consumer via call center representative and described the occurrence of appetite absent in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17-JUN-2023, the patient received the 1st dose of Shingrix (right arm). In JUN-2023, an unknown time after receiving Shingrix, the patient experienced appetite absent (Verbatim: No appetite), stomach discomfort (Verbatim: Sick to her stomach), nausea (Verbatim: Nausea), headache (Verbatim: Headache) and bedridden (Verbatim: Spent 2 days in bed). On 17-JUN-2023, the patient experienced pain in arm (Verbatim: Sore Arm). On 18-JUN-2023, the patient experienced swelling arm (Verbatim: Swollen Arm /knot on arm) and itchy upper limbs (Verbatim: Itchy Arm). On 20-JUN-2023, the patient experienced feeling unwell (Verbatim: Does not feel well). On 26-JUN-2023, the patient experienced dizziness (Verbatim: Dizziness). The patient was treated with dramamine (nos) (Dramamine). In JUN-2023, the outcome of the appetite absent, nausea and headache were resolved and the outcome of the bedridden was resolved (duration 2 days).  On 21-JUN-2023, the outcome of the feeling unwell was resolved (duration 1 day). The outcome of the stomach discomfort and dizziness were not resolved and the outcome of the swelling arm, itchy upper limbs and pain in arm were resolved (duration 3 days).   It was unknown if the reporter considered the appetite absent, stomach discomfort, dizziness, nausea, headache, feeling unwell, swelling arm, itchy upper limbs, pain in arm and bedridden to be related to Shingrix.     It was unknown if the company considered the appetite absent, stomach discomfort, dizziness, nausea, headache, feeling unwell, swelling arm, itchy upper limbs, pain in arm and bedridden to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-JUN-2023 The patient self-reported this case. The patient's arm was sore on the vaccination day evening.  The next day the patient reported that her arm was very sore, itchy, swollen, and she had a knot, and these side effects all went away after 3 to 4 days (no specific date provided).  Patient also reported that she did not feel well, and it comes and goes that on Tuesday and Wednesday. The patient had nausea, dizziness, felt sick to her stomach, had no appetite and had a headache. Patient took Dramamine one day and spent 2 days in bed during this time.  Patient also reported that all the side effects went away but on reporting day, she was feeling dizzy and sick to her stomach again.  Reported all the patient was able to share about these events. The reporter consent to follow up with herself and with healthcare professional.
Severe muscle pain all over body especially head. I could barely lift head 1/2 inch without excruciating pain. Fever, chills, and profuse sweating. I was literally frozen and couldn't move which lasted almost 48 hours. Would have gone to the ER but did not have the energy or strength to call an ambulance from my phone. Very scary.
Patient experienced numbness and tingling to left side of face, tremors, sharp shooting pain in the left temporal area, left upper arm sore shoulder to elbow. Patient was also extremely cold so treated her with warm blankets. Gave patient water and checked blood pressure and hooked her up to heart monitor. Blood pressure was 138/74, pulse 60 and respirations 24. No mediacations were given while in our care. Continued to monitor paient for 2 hours at the clinic site. Patient did not want to go to the hospital
took vax 3AUG93 & on 3AUG began vomiting & cont to vomit to present 23AUG; vomits daily; nauseated some part of everyday; 5AUG felt like ran fever did not take temp dehydrated on 10AUG; 20AUG c/o SOB & had enlarged nodes in neck;
Information has been received from an LPN concerning a 54 year old white female with allergies to penicillin , dibromopropamidine isethionate + promethazine, doxycline calcium, sulfa, iodine and IV contrast who on 14JUL2003 at 3:00 pm was vaccinated SC in the left upper arm with a first dose of pneumococcal vaccine 23 polyvalent. At the time of vaccination, the pt had "bronchospastic dis." The pt called back the next day on 15JUL2003 and reported (also reported as "within 24 hours of vaccination) a large red area on the left upper arm that was warm to touch with no blister (previously reported as urticaria). The pt was seen over about a three week pd. None of the reactions were severe but appeared to be a type three allergic reaction. Unspecified medical attention was sought and no treatment was required. There was no product quality complaint involved. The physician also mentioned two other patient who had a similar experience following exposure to pneumococcal vaccine 23 polyvalent. Follow up information indicated that the pt recovered.
left arm is hurting; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional information was provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received the shot in left arm and it was hurting after the shot at the time of reporting.
PAIN UNDER THE ARM WHERE THE  VACCINE WAS ADMINISTERED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 11-MAR-2021, the subject experienced pain under the arm where the vaccine was administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain under the arm where the vaccine was administered. This report was non-serious.
I had a couple of bruises to pop up but I didn't known if I hit my leg on something or not. Still this is the longest I've ever had bruises to last on my leg. It feels over worked. Also, my body feels shaky sometimes. I'm not sure if it's my nerves since I just lost someone close to me or from this shot. I've never felt shaky at random like this. It feels like my heart races when that occurs, too. It never last long, either.
PNEUMOVAX given SQ in (R) arm on 3/1/12. Pt went to an urgent care clinic on 3/4/12 for redness, swelling and pain at the injection site. Pt was given an IM injection (pt does not know name) and PO LEVAQUIN for 10 days.
Case number PHEH2015US022251, is an initial spontaneous report from a nurse received on 28 Oct 2015. This report refers to a female patient of an unknown age. Medical history and concomitant medications were not reported. The patient received 0.5 ml of FLUVIRIN (batch number: 1516201) via subcutaneous route in error on an unknown date. The case was assessed as non-serious. No adverse event was reported following this maladministration.